UK Issues Health Warning on Finasteride Due to Potential Long-Term Sexual Side Effects
The UK has issued a new health warning for those taking finasteride, a medication used to treat hair loss and enlarged prostate. This warning is important for both current users and potential patients considering this treatment.
Finasteride works by inhibiting the enzyme 5 alpha-reductase, which converts testosterone to dihydrotestosterone (DHT). Lowering DHT can help with conditions like male pattern baldness and benign prostatic hyperplasia. However, officials are now raising concerns about the possible side effects associated with its use.
Reports indicate that some users may experience sexual side effects, including erectile dysfunction and reduced libido. Additionally, there are claims that these effects might not resolve after stopping the medication. Health experts advise anyone facing these symptoms to consult their GP for proper evaluation and support.
Authorities highlight the importance of awareness regarding such side effects, urging patients to discuss any worries with their healthcare providers before starting treatment.
This warning emphasizes the need for careful consideration when using finasteride. "Patients should be informed of the potential risks," said a health official.
This article is for general information only and is not a substitute for professional medical advice. Always speak to a GP or qualified health professional about your own health.